Literature DB >> 26585332

Cancer stem cells in laryngeal cancer: what we know.

A Greco1, Maria Ida Rizzo2, A De Virgilio3, A Gallo1, M Fusconi1, G Pagliuca1, S Martellucci1, R Turchetta1, M De Vincentiis1.   

Abstract

Cancer stem cells (CSCs) are a group of cells with eternal life or infinite self-renewal ability, which have high migrating, infiltrative, and metastatic abilities. Though CSCs only account for a small proportion in tumors, the high resistance to traditional therapy exempts them from therapy killing and thus they can reconstruct tumors. Previous studies found that heterogeneity of cancer cells extensively exists in head and neck cancers. Our current knowledge, about CSCs in the laryngeal cancer (LC), largely depends on head and neck studies. Given the lack of systematic data about CSCs in LC, we propose a review of the literature, reporting the evidences of CSCs in tumorigenesis of LC, with the purpose to provide new insights into the prevention and/or treatment of laryngeal carcinoma.

Entities:  

Keywords:  Cancer stem cells; Epithelial-to-mesenchymal transition; Laryngeal carcinoma; Side population; Stemness markers

Mesh:

Substances:

Year:  2015        PMID: 26585332     DOI: 10.1007/s00405-015-3837-9

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  68 in total

1.  Resistance to apoptosis-inducing stimuli in CD44+ head and neck squamous cell carcinoma cells.

Authors:  Kazuaki Chikamatsu; Hiroki Ishii; Goro Takahashi; Atsushi Okamoto; Motohiro Moriyama; Koichi Sakakura; Keisuke Masuyama
Journal:  Head Neck       Date:  2011-04-05       Impact factor: 3.147

2.  Cancer associated fibroblasts: the dark side of the coin.

Authors:  Paolo Cirri; Paola Chiarugi
Journal:  Am J Cancer Res       Date:  2011-03-12       Impact factor: 6.166

Review 3.  Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

Authors:  Thomas Brabletz; Andreas Jung; Simone Spaderna; Falk Hlubek; Thomas Kirchner
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

4.  CD44 expression predicts local recurrence after radiotherapy in larynx cancer.

Authors:  Monique C de Jong; Jimmy Pramana; Jacqueline E van der Wal; Martin Lacko; Carine J Peutz-Kootstra; Jos M de Jong; Robert P Takes; Johannes H Kaanders; Bernard F van der Laan; Jasper Wachters; Jeroen C Jansen; Coen R Rasch; Marie-Louise F van Velthuysen; Reidar Grénman; Frank J Hoebers; Ed Schuuring; Michiel W van den Brekel; Adrian C Begg
Journal:  Clin Cancer Res       Date:  2010-09-13       Impact factor: 12.531

5.  Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer.

Authors:  Yu-Chih Chen; Yi-Wei Chen; Han-Shui Hsu; Ling-Ming Tseng; Pin-I Huang; Kai-Hsi Lu; Dow-Tien Chen; Lung-Kuo Tai; Ming-Chi Yung; Shih-Ching Chang; Hung-Hai Ku; Shih-Hwa Chiou; Wen-Liang Lo
Journal:  Biochem Biophys Res Commun       Date:  2009-05-18       Impact factor: 3.575

6.  Enhancive effects of Lewis y antigen on CD44-mediated adhesion and spreading of human ovarian cancer cell line RMG-I.

Authors:  Lili Gao; Limei Yan; Bei Lin; Jian Gao; Xiuyun Liang; Yanyan Wang; Juanjuan Liu; Shulan Zhang; Masao Iwamori
Journal:  J Exp Clin Cancer Res       Date:  2011-02-07

7.  Anti-tumor effect against human cancer xenografts by a fully human monoclonal antibody to a variant 8-epitope of CD44R1 expressed on cancer stem cells.

Authors:  Kazue Masuko; Shogo Okazaki; Mayumi Satoh; Goh Tanaka; Tatsuya Ikeda; Ryota Torii; Eri Ueda; Takashi Nakano; Masaaki Danbayashi; Tomoyo Tsuruoka; Yoshiya Ohno; Hideki Yagi; Noritsugu Yabe; Hideaki Yoshida; Tomoyuki Tahara; Shiro Kataoka; Taichi Oshino; Takayuki Shindo; Shin-ichiro Niwa; Takatsugu Ishimoto; Hideo Baba; Yoshiyuki Hashimoto; Hideyuki Saya; Takashi Masuko
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

Review 8.  Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis.

Authors:  Jianqiang Chen; Jianding Zhou; Jie Lu; Hua Xiong; Xueli Shi; Liang Gong
Journal:  BMC Cancer       Date:  2014-01-13       Impact factor: 4.430

9.  Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma.

Authors:  Lan Yu; Lei Zhou; Shiwu Wu; Xiaomeng Gong; Zhenzhong Feng; Li Ma; Bo Zhu; Nan Yao; Danna Wang; Huiming Dong
Journal:  World J Surg Oncol       Date:  2014-04-24       Impact factor: 2.754

10.  Identification of cancer stem-like side population cells in purified primary cultured human laryngeal squamous cell carcinoma epithelia.

Authors:  Chun-Ping Wu; Liang Zhou; Ming Xie; Huai-Dong Du; Jie Tian; Shan Sun; Jin-Yan Li
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

View more
  9 in total

1.  Annexin A2 is an independent prognostic biomarker for evaluating the malignant progression of laryngeal cancer.

Authors:  Shi Luo; Chubo Xie; Ping Wu; Jian He; Yaoyun Tang; Jing Xu; Suping Zhao
Journal:  Exp Ther Med       Date:  2017-10-12       Impact factor: 2.447

Review 2.  Targeting cancer stem cell pathways for cancer therapy.

Authors:  Liqun Yang; Pengfei Shi; Gaichao Zhao; Jie Xu; Wen Peng; Jiayi Zhang; Guanghui Zhang; Xiaowen Wang; Zhen Dong; Fei Chen; Hongjuan Cui
Journal:  Signal Transduct Target Ther       Date:  2020-02-07

Review 3.  Potentials of lncRNA-miRNA-mRNA networks as biomarkers for laryngeal squamous cell carcinoma.

Authors:  Yan Lv; Yanhua Wang; Zhikai Zhang
Journal:  Hum Cell       Date:  2022-10-01       Impact factor: 4.374

4.  Silencing PLOD2 attenuates cancer stem cell-like characteristics and cisplatin-resistant through Integrin β1 in laryngeal cancer.

Authors:  Meiyan Song; Xing Liu; Tao Li; Yueqin Zhang; Xiaoyan Zhao; Wen Sun; Zhen Li
Journal:  Transl Oncol       Date:  2022-06-03       Impact factor: 4.803

5.  A novel signature derived from metabolism-related genes GPT and SMS to predict prognosis of laryngeal squamous cell carcinoma.

Authors:  Yujie Shen; Qiang Huang; Yifan Zhang; Chi-Yao Hsueh; Liang Zhou
Journal:  Cancer Cell Int       Date:  2022-07-08       Impact factor: 6.429

Review 6.  Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting.

Authors:  Shweta Bisht; Manisha Nigam; Shyam S Kunjwal; Plygun Sergey; Abhay Prakash Mishra; Javad Sharifi-Rad
Journal:  Stem Cells Int       Date:  2022-06-28       Impact factor: 5.131

Review 7.  Targeting cancer stem cell pathways for cancer therapy.

Authors:  Liqun Yang; Pengfei Shi; Gaichao Zhao; Jie Xu; Wen Peng; Jiayi Zhang; Guanghui Zhang; Xiaowen Wang; Zhen Dong; Fei Chen; Hongjuan Cui
Journal:  Signal Transduct Target Ther       Date:  2020-02-07

8.  Identification of prognostic immune genes in laryngeal cancer.

Authors:  Huan Xiao; Qi-Sheng Su; Chao-Qian Li
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

9.  A biflavonoid-rich extract from Selaginella moellendorffii Hieron. induces apoptosis via STAT3 and Akt/NF-κB signalling pathways in laryngeal carcinoma.

Authors:  Huiqi Huang; Ji Hao; Kejian Pang; Yibing Lv; Dingrong Wan; Chaoqun Wu; Yuanren Ma; Xinzhou Yang; Wei K Zhang
Journal:  J Cell Mol Med       Date:  2020-09-01       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.